HER2-Positive Early Stage Breast Cancer Completed Phase 2 Trials for Hyaluronidase (human recombinant) (DB06205)

Also known as: HER2-Positive Early Breast Cancer / HER2-positive early-stage breast cancer / Early Stage HER2+ Breast Cancer / HER2 Positive Early Breast Cancer

IndicationStatusPhase
DBCOND0063722 (HER2-Positive Early Stage Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03674112A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerTreatment